Plant ID: NPO1179
Plant Latin Name: Anaxagorea luzonensis
Taxonomy Genus: Anaxagorea
Taxonomy Family: Annonaceae
NCBI TaxonomyDB:
235716
Plant-of-the-World-Online:
72039-1
Myanmar; Philippines; Indonesia; Cambodia; Vietnam; China; Sri Lanka; Thailand
GAA; | |
MAOA; | |
SMN1;SMN2; |
Cytochrome P450 Enzymes: | CYP3A4; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Oxidoreductase | MAOA | Monoamine oxidase A | P21397 | CHEMBL1951 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0042737; drug catabolic process | 2.056E-04 | 6.442E-01 | CYP3A4, MAOA |
BP | GO:0008152; metabolic process | GO:0055114; oxidation-reduction process | 3.867E-04 | 6.763E-01 | CYP3A4, GAA, MAOA |
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 6.212E-04 | 6.763E-01 | CYP3A4 |
BP | GO:0008152; metabolic process | GO:0000023; maltose metabolic process | 6.212E-04 | 6.763E-01 | GAA |
MF | GO:0003824; catalytic activity | GO:0004574; oligo-1,6-glucosidase activity | 4.141E-04 | 6.763E-01 | GAA |
MF | GO:0003824; catalytic activity | GO:0070576; vitamin D 24-hydroxylase activity | 6.212E-04 | 6.763E-01 | CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0032450; maltose alpha-glucosidase activity | 6.212E-04 | 6.763E-01 | GAA |
CC | GO:0016020; membrane | GO:0031090; organelle membrane | 9.939E-03 | 1.000E+00 | CYP3A4, GAA, MAOA |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 7.007E-05 | 1.612E-03 | MAOA, CYP3A4 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 9.049E-04 | 1.041E-02 | MAOA, GAA, CYP3A4 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00340 | Histidine metabolism | 4.792E-03 | 1.856E-02 | MAOA |
09100 Metabolism | 09105 Amino acid metabolism | hsa00360 | Phenylalanine metabolism | 3.396E-03 | 1.856E-02 | MAOA |
09100 Metabolism | 09105 Amino acid metabolism | hsa00330 | Arginine and proline metabolism | 9.963E-03 | 1.856E-02 | MAOA |
09160 Human Diseases | 09164 Substance dependence | hsa05031 | Amphetamine addiction | 1.333E-02 | 1.856E-02 | MAOA |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.294E-02 | 1.856E-02 | CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 1.155E-02 | 1.856E-02 | CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.452E-02 | 1.856E-02 | CYP3A4 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 1.413E-02 | 1.856E-02 | CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|